Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Moderna, Inc. (MRNA) – Moderna, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Moderna (MRNA) trades at $49.13, down 0.14% on the day, reflecting ongoing pressure from declining COVID-19 vaccine sales. The stock exhibits a bearish technical signal with key support at $47 and resistance at $50. Financially, revenue fell to $3.2B in 2024 with a net loss of $3.56B, though recent quarters have beaten EPS estimates. Cash flow remains negative from operations, highlighting challenges in transitioning beyond pandemic-related products.
Outlook is speculative with high risk; growth depends on pipeline success in flu and other mRNA vaccines. Analyst consensus is mixed with a $44.60 price target below current levels, indicating caution amid uncertain commercial execution and competitive pressures.
Read full analysis

Key Stats

  • Market Cap
    $19.34B
  • Sector
    Health
  • 3M Drawdown
    -22.67%
  • Enterprise Value
    $14.85B
  • Dividend Yield
    -
  • Trading Activity
    53% Buy | 47% Sell
  • Typical Hold Time
    76 days
$51.71
52W Low: $22.36
20 Nov 2025
52W High: $57.8
04 Mar 2026

Moderna, Inc. (MRNA) is currently valued at a market capitalization of $19.34B, with an enterprise value of $14.85B. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $57.8, highlighting its annual price range. Over the past three months, Moderna, Inc. has recorded a drawdown of -22.67%, reflecting recent price volatility. Moderna, Inc. offers a dividend yield of -. On average, investors hold Moderna, Inc. for approximately 76 days, indicating typical investor behavior on the platform.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.


Technical Indicators
|
|
|
Overall Summary
Bearish (7)Neutral (1)Bullish (19)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $19.34B
  • Sector
    Health
  • 3M Drawdown
    -22.67%
  • Enterprise Value
    $14.85B
  • Dividend Yield
    -
  • Trading Activity
    53% Buy | 47% Sell
  • Typical Hold Time
    76 days
$51.71
52W Low: $22.36
20 Nov 2025
52W High: $57.8
04 Mar 2026

Moderna, Inc. (MRNA) is currently valued at a market capitalization of $19.34B, with an enterprise value of $14.85B. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $57.8, highlighting its annual price range. Over the past three months, Moderna, Inc. has recorded a drawdown of -22.67%, reflecting recent price volatility. Moderna, Inc. offers a dividend yield of -. On average, investors hold Moderna, Inc. for approximately 76 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!